Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Financials
Pharma
Neurocrine pays $2.9B for Soleno, its largest M&A deal ever
The acquisition of Soleno and its hyperphagia drug Vykat XR comes a few months after Neurocrine unveiled an obesity pipeline.
Angus Liu
Apr 6, 2026 10:30am
Large pharma companies reduced head counts by over 22K in 2025
Mar 23, 2026 4:25pm
Legend sloughs off Carvykti threat from J&J's Tecvayli
Mar 12, 2026 2:00pm
Orphan drug sales to surge past $400B in 2032: report
Mar 12, 2026 8:20am
Lilly shines in Q4 as peers brace for 2026 slowdown
Mar 11, 2026 3:00pm
Galderma doubles Nemluvio peak sales outlook to $4B-plus
Mar 5, 2026 11:20am
